Reopening and reimbursement progress
Financial highlights Q1 2021
Net sales amounted to 13,2 MSEK (11,4), an increase of 16 percent over the same period 2020
- Operating result amounted to -7,1 MSEK (-12,5)
- Net result after financial items amounted to -7,7 MSEK (-12,8)
-
Earnings per share was -
0,12 SEK (-0,23) - Cash Balance amounted to 44,4 MSEK (8,8)
- Average Daily Treatment Revenue (ADTR)* was 130 TSEK (118), an increase of 10 percent over the same period in 2020
Significant events during the period
The Extraordinary General Meeting on
January 11 approved the Board of Directors' resolution on the directed issue of shares made on22 December 2020
Business highlights during the period
Dignitana expanded agreement withGenesisCare to includeUnited States - Mammazentrum Hamburg selected
DigniCap Delta to provide upgraded scalp cooling therapy Dignitana announced the specific CPT codes for DigniCap which will be available to patients on1 July 2021 - The Company highlighted new clinical guidelines from leading oncology organizations around the world which recommend scalp cooling
- The Company has repaid in full the 20 MSEK unsecured loan received from Adma Förvaltnings AB in the third period of 2020
Significant events after the period
Dignitana published the 2020 Annual Report
Business highlights after the period
Dignitana -backed insurance legislation clearedTexas House committee
DIGNITANA GROUP | Q1 2021 | Q1 2020 | Full Year 2020 |
Net sales, TSEK | 13 165 | 11 393 | 46 629 |
Total revenues, TSEK | 14 157 | 12 478 | 49 956 |
Net profit after financial items, TSEK | -7 664 | -12 755 | -52 963 |
Cash and bank balances, TSEK | 44 366 | 8 768 | 78 770 |
Earnings per share before and after dilution, SEK | -0,12 | -0,23 | -0,96 |
Average Daily Treatment Revenue*, TSEK | 130 | 118 | 120 |
* ADTR includes pay-per-treatment revenue from patients and facilities. Does not include lease revenue or disposable sales.
All financial reports are available at www.dignitana.com/investor-relations/financial-reports/
This disclosure contains information that
For More Information Contact
About
https://news.cision.com/dignitana-ab/r/dignitana-ab-publishes-q1-2021-interim-report,c3350261
https://mb.cision.com/Main/2116/3350261/1420000.pdf
(c) 2021 Cision. All rights reserved., source